KO vs LULU: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Lululemon Athletica Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-21.
The Coca-Cola Company ยท Consumer Defensive
$88.71
+15.5% upside to fair value
Med Conviction Grade C High Quality
VS
Lululemon Athletica Inc. ยท Consumer Cyclical
$98.06
+1.5% upside to fair value
Low Conviction Grade C
QuantHub Verdict
KO has more upside to fair value (+15.5%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric KO LULU
Current Price $88.71 $98.06
Fair Value Estimate $102.44 $99.50
Upside to Fair Value +15.5% +1.5%
Market Cap $381.7B $11.1B
Forward P/E โ€” โ€”
EV / EBITDA 20.8x 4.6x
Price / Sales 7.6x 1.0x
Price / FCF 26.7x 8.2x
Revenue Growth YoY +6.7% -4.3%
Gross Margin 61.9% 56.1%
Operating Margin 29.6% 17.8%
Return on Equity 43.0% 29.7%
Dividend Yield 2.37% 0%
FCF Yield 3.75% 12.24%
Analyst Consensus Strong Buy Sell
Investment Thesis
KO โ€” The Coca-Cola Company
The Coca-Cola Company is a global non-alcoholic beverage concentrate, brand-management and bottling-system business with products sold in more than 200 countries and territories, supported by powerful trademarks, 2.2 billion daily servings and an entrenched distribution network. Business quality is high: TTM gross, operating and net margins are 61.9%, 29.6% and 28.6%, respectively, ROE is 43.0%, โ€ฆ
LULU โ€” Lululemon Athletica Inc.
Lululemon Athletica designs and retails premium athletic apparel and accessories through company-owned stores and direct-to-consumer channels, with roughly 39,000 employees and a brand built on technical fabrics and community-led fitness positioning. The business still earns high returns on equity of 29.7% and generates $12.00 of free cash flow per share on $97.70 of revenue per share, with TTM gโ€ฆ
Accumulation Zones
Metric KO LULU
Zone Low $76.83 $74.62
Zone High $87.07 $84.58
In Buy Zone? No No
โ† KO Research    LULU Research โ†’    All Research